COVID-19 Update - This is to inform you that the Government of India has announced a complete lockdown in India 22nd March 2020 to 3rd May 2020. As a result, our offices will now be closed till 3rd May 2020 and all our employees will be working from home. Office telephones will not be answered, and therefore you are requested to direct all your queries related to manuscript submission, review process, publication etc. at below mentioned details. editor@innovativepublication.com, rakesh.its@gmail.com, Mob. 8826373757, 8826859373, 9910947804

Article Access statistics

Viewed: 550

Emailed: 0

PDF Downloaded: 207

IP Indian Journal of Clinical and Experimental Dermatology


Mycetoma- A resurgence


Full Text PDF Share on Facebook Share on Twitter


Author Details : M. Mani Surya Kumar, V. Senthil Kumar, Parimalam Kumar, V. Anandan

Volume : 4, Issue : 1, Year : 2018

Article Page : 44-47


Suggest article by email

Abstract

Mycetoma is a localized chronic, suppurative granulomatous disorder of subcutaneous tissue, skin and bones, mainly of feet, characterized by a triad of grains, tumour and tracts. It is commonly seen in tropical and subtropical areas. Based on causative organisms it is classified into eumycetoma caused by fungus, and actinomycetoma caused by bacteria. Color of grains also helps in differentiating the organisms. Black grains are always produced by fungi; pale grains are produced by bacteria and fungus. Diagnosis is based on the classical clinical presentation, histopathology and microbiological examination. Serological tests are not helpful. Molecular techniques to detect antigens are still under study. Eumycetoma is very resistant to treatment. Actinomycetoma responds well to prolonged antibiotic therapy.1,2 We present here in detail a series of five cases of mycetoma diagnosed in our hospital in a span of six months.

Keywords: Actinomycetoma, Eumycetoma, Madura foot.

Doi : 10.18231/.2018.0010

How to cite : Kumar M M S, Kumar V S, Kumar P, Anandan V, Mycetoma- A resurgence. IP Indian J Clin Exp Dermatol 2018;4(1):44-47

Copyright © 2018 by author(s) and IP Indian J Clin Exp Dermatol. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0) (creativecommons.org)